# G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission

> **NCT00233961** · PHASE1 · COMPLETED · sponsor: **Herbert Irving Comprehensive Cancer Center** · enrollment: 20 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** filgrastim

## Key facts

- **NCT ID:** NCT00233961
- **Lead sponsor:** Herbert Irving Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-11
- **Final completion:** 2008-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233961, "G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00233961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*